Protective effect of erdosteine on cyclosporine induced chronic nephrotoxicity in rats

Nephro-Urology Monthly

Volumn 3, Issue 4, 2011, Pages 172-176

  Uz, Ebru ^a   Uz, Burak ^a   Kaya, Arif ^a   Akdeniz, Derya ^a   Ruzgaresen, Nuket Bavbek ^a   Uz, Efkan ^b   Turgut, Faruk Hilmi ^a   Bayrak, Reyhan ^a   Akcay, Ali ^a  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Erdosteine cyclosporine oxidative stress

Indexed keywords

CYCLOSPORIN; ERDOSTEINE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; RENAL PROTECTION;

EID: 80053012527     PISSN: 22517006     EISSN: 22517014     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Slattery C, Campbell E, McMorrow T, Ryan MP. Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition. Am J Pathol. 2005;167(2):395-407.
2. Ural M, Özgüner M, enal D, Sütçü R, Deliba N. Siklosporin A'n n s çanlarda olu turdu u nefrotoksisiteye Vitamin C ile Vitamin E'nin ve verapamilin etkilerinin k mikroskobunda de erlendirilmesi. Ti{dotless}p Fak Derg. 2009;12(4): 28-35.
3. Kumar KV, Naidu MU, Shifow AA, Prayag A, Ratnakar KS. Melatonin: an antioxidant protects against cyclosporineinduced nephrotoxicity. Transplantation. 1999;67(7): 1065-8.
4. Uz E, Bayrak O, Kaya A, Bayrak R, Uz B, Turgut FH, et al. Nigella sativa oil for prevention of chronic cyclosporine nephrotoxicity: an experimental model. Am J Nephrol. 2008;28(3): 517-22.
5. Fadillioglu E, Erdogan H, Sogut S, Kuku I. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. J Appl Toxicol. 2003;23(1): 71-4.
6. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1): 265-75.
7. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34(3): 497-500.
8. Durak I, Yurtarslanl Z, Canbolat O, Akyol O. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin Chim Acta. 1993;214(1): 103-4.
9. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1): 158-69.
10. Bergmeyer HU. Methods of enzymatic analysis. New York and London: Academic Press; 1974. p: 673-7.
11. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990;186: 421-31.
12. dos Santos OF, Boim MA, Barros EJ, Pirotzky E, Braquet P, Schor N. Nephrotoxicity of cyclosporine: the role of platelet-activating factor and thromboxane. Lipids. 1991;26(12): 1320-3.
13. Wang C, Salahudeen AK. Cyclosporine nephrotoxicity: attenuation by an antioxidant-inhibitor of lipid peroxidation in vitro and in vivo. Transplantation. 1994;58(8): 940-6.
14. Galletti P, Di Gennaro CI, Migliardi V, Indaco S, Della Ragione F, Manna C, et al. Diverse effects of natural antioxidants on cyclosporin cytotoxicity in rat renal tubular cells. Nephrol Dial Transplant. 2005;20(8): 1551-8.
15. Krauskopf A, Buetler TM, NguyenNS, Mace K, Ruegg UT. Cyclosporin A-induced free radical generation is not mediated by cytochrome P-450. Br J Pharmacol. 2002;135(4): 977-86.
16. Rabl H, Khoschsorur G, Colombo T, Petritsch P, Rauchenwald M, Koltringer P, et al. A multivitamin infusion prevents lipid peroxidation and improves transplantation performance. Kidney Int. 1993;43(4): 912-7.
17. Peresleni T, Noiri E, Bahou WF, Goligorsky MS. Antisense oligodeoxynucleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury. Am J Physiol. 1996;270(6 Pt 2):F 971-7.
18. Perez de Hornedo J, de Arriba G, Calvino M, Benito S, Parra T. Cyclosporin A causes oxidative stress and mitochondrial dysfunction in renal tubular cells. Nefrologia. 2007;27(5): 565-73.
19. Parra Cid T, Conejo Garcia JR, Carballo Alvarez F, de Arriba G. Antioxidant nutrients protect against cyclosporine A nephrotoxicity. Toxicology. 2003;189(1-2): 99-111.
20. Yildirim Z, Sogut S, Odaci E, Iraz M, Ozyurt H, Kotuk M, et al. Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats. Pharmacol Res. 2003;47(2): 149-56.
21. Durak I, Karabacak HI, Buyukkocak S, Cimen MY, Kacmaz M, Omeroglu E, et al. Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine. Protective effects of vitamins E and C. Nephron. 1998;78(2): 207-11.
22. Tariq M, Morais C, Sobki S, Al Sulaiman M, Al Khader A. N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. Nephrol Dial Transplant. 1999;14(4): 923-9.
23. Selcoki Y, Uz E, Bayrak R, Sahin S, Kaya A, Uz B, et al. The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats. Toxicology. 2007;239(1-2): 53-9.
24. Erarslan E, Ekiz F, Uz B, Koca C, Turkcu UO, Bayrak R, et al. Effects of erdosteine on cyclosporine-A-induced hepatotoxicity in rats. Drug Chem Toxicol. 2011;34(1): 32-7.